Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12946411 | 0.83 | TSHR (0.48) | TSHRLMNALRRK2ALDH1A1HPGD | |
| SCHEMBL10000616 | 0.82 | CYP2A6 (0.42) | TSHRLRRK2ALDH1A1HPGDCNR2 | |
| SCHEMBL25392183 | 0.80 | SQOR (0.44) | TSHRLMNAALDH1A1HPGDCYP11B2 | |
| SCHEMBL8311135 | 0.80 | HPGD (0.43) | TSHRALDH1A1HPGDCYP11B2CNR2 | |
| SCHEMBL3291080 | 0.79 | DPP4 (0.53) | LRRK2ARALDH1A1CYP11B2ADORA2A | |
| SCHEMBL3296198 | 0.79 | CHUK (0.45) | ALDH1A1HPGDCYP11B2ADORA2AADORA1 | |
| SCHEMBL4160810 | 0.79 | CYP2A6 (0.52) | ADORA2ANPC1CASP3RAB9ASMN1; SMN2 | |
| SCHEMBL31267979 | 0.79 | CNR2 (0.49) | TSHRLRRK2ALDH1A1HPGDCYP11B2 | |
| SCHEMBL3293427 | 0.79 | ALDH1A1 (0.47) | LMNAARALDH1A1HPGDADORA2A | |
| SCHEMBL28652835 | 0.78 | GCK (0.42) | LMNAALDH1A1HPGDCNR2PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150340628-A1 | METAL COMPLEX COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2015-11-26 | — | — | US | disclosed |
| US-9096529-B2 | Metal complex compound and organic light emitting diode device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-08-04 | — | — | US | disclosed |
| EP-2721019-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | Agios Pharmaceuticals, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012171337-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| US-20120012824-A1 | METAL COMPLEX COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150340628-A1 | METAL COMPLEX COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME | AP1M1, MT-CO1, AP2M1 | TSHR 2320/4885LMNA 3816/4885LRRK2 203/4885 |
| US-20120012824-A1 | METAL COMPLEX COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME | AP1M1, MT-CO1, AP2M1 | TSHR 2320/4885LMNA 3816/4885LRRK2 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.